Prenatal and postnatal histories of very low birthweight infants who developed hepatoblastoma

Pediatrics International

Volumn 41, Issue 1, 1999, Pages 82-89

  Maruyama, Kenichi ^a   Ikeda, Hitoshi ^a   Koizumi, Takenobu ^a   Tsuchida, Yoshiaki ^a  

^a Gumna Children S Medical Center   (Japan)

Author keywords

Hepatoblastoma; Postnatal history; Prenatal history; Very low birthweight

Indexed keywords

FUROSEMIDE;

ARTICLE; BIRTH WEIGHT; CHILD; CHOLELITHIASIS; CHRONIC LUNG DISEASE; CLINICAL ARTICLE; CONGENITAL MALFORMATION; CYTOMEGALOVIRUS INFECTION; ENVIRONMENTAL FACTOR; FEMALE; GENETIC PREDISPOSITION; GESTATIONAL AGE; HEPATOBLASTOMA; HUMAN; INFANT; JAPAN; MALE; OXYGEN THERAPY; PATENT DUCTUS ARTERIOSUS; POSTNATAL CARE; PRENATAL CARE; PRIORITY JOURNAL; RESPIRATORY DISTRESS SYNDROME; RISK FACTOR; VERY LOW BIRTH WEIGHT;

CHILD; CHILD, PRESCHOOL; FEMALE; GESTATIONAL AGE; HEPATOBLASTOMA; HUMANS; INFANT; INFANT, NEWBORN; INFANT, VERY LOW BIRTH WEIGHT; LIVER NEOPLASMS; MALE; MATERNAL EXPOSURE; MEDICAL HISTORY TAKING; PATERNAL EXPOSURE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 0033038064     PISSN: 13288067     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1442-200x.1999.01022.x     Document Type: Article

References (21)

1. Haas JE, Muczynski KA, Krailo M et al. Histopathology and prognosis in childhood hepatoblastoma and hepatocarcinoma. Cancer 1989; 64: 1082-95.
2. Albrecht S, von Schweinitz D, Waha A, Kraus JA, von Diemling A, Pietsch T. Loss of maternal alleles on chromosome arm 11p in hepatoblastoma. Cancer Res. 1994; 54: 5041-4.
3. Kurahashi H, Takami K, Oue T et al. Biallelic inactivation of the APC gene in hepatoblastoma. Cancer Res. 1995; 55: 5007-11.
4. Giardiello FM, Peterson GM, Brensinger JD et al. Hepatoblastoma and APC gene mutation in familial adenomatous polyposis. Gut 1996; 39: 867-9.
5. Narod SA, Hawkins MM, Robertson CM, Stiller CA. Congenital anomalies and childhood cancer in Great Britain. Am. J. Hum. Genet. 1997; 60: 474-85.
6. Otten J, Smets R, De Jager R, Gerard A, Mauras R. Hepatoblastoma in an infant after contraceptive intake during pregnancy. N. Engl. J. Med. 1977; 297: 222.
7. Khan A, Bader JL, Hoy GR, Sinks LF. Hepatoblastoma in child with fetal alcohol syndrome. Lancet 1979; i: 1403.
8. Melamed I, Bujanover Y, Hammer J, Spirer Z. Hepatoblastoma in an infant born to a mother after hormonal treatment for sterility. N. Engl. J. Med. 1982; 307: 820.
9. Buckley JD, Sather H, Ruccione K et al. A case-control study of risk factors for hepatoblastoma: A report from the Children's Cancer Study Group. Cancer 1989; 64: 1169-76.
10. Ikeda H, Matsuyama S, Tanimura M. Association between hepatoblastoma and very low birth weight: A trend or a chance? J. Pediatr. 1997; 130: 557-60.
11. Statistics and Information Department, Minister's Secretariat, Ministry of Health and Welfare. Vital Statistics of Japan. The Statistics and Information Department, Tokyo, 1993.
12. Ikeda H, Hachitanda Y, Tanimura M, Maruyama K, Koizumi T, Tsuchida Y. Unfavorable hepatoblastoma develops in children of very low birth weight: Results of a surgical and pathologic review. Cancer 1998; 82: 1789-96.
13. Japanese Society of Pediatric Surgeons. Announcement of the Committee on Malignant Tumor of the Japanese Society of Pediatric Surgeons. J. Jpn Soc. Pediatr. Surg. 1980; 16: 856-69.
14. Daling JR, Starzyk P, Olshan AF, Weiss NS. Birth weight and the incidence of childhood cancer. J. Natl Cancer Inst. 1984; 72: 1039-41.
15. Leisenring WM, Breslow NE, Evans IE, Beckwith JB, Coppes MJ, Grundy P. Increased birth weights of National Wilms' Tumor Study patients suggest a growth factor excess. Cancer Res. 1994; 54: 4680-3.
16. Gerber MA, Carol Shieh YS, Shim K-S et al. Detection of replicative hepatitis C virus sequences in hepatocellular carcinoma. Am. J. Pathol. 1992; 141: 1271-7.
17. Lu LJ, Anderson LM, Jones AB et al. Persistence, gestation stage-dependent formation and interrelationship of benzo[a]pyrene-induced DNA adducts in mothers, placentae and fetuses of Erythrocebus patas monkeys. Carcinogenesis 1993; 14: 1805-13.
18. Kensler TW, Bush DM, Kozumbo WJ. Inhibition of tumor promotion by a biomimetic superoxide dismutase. Science 1983; 221: 75-7.
19. Bucher JR, Huff J, Haseman JK, Eustis SL, Davis WE, Meierhenry EF. Toxicology and carcinogenicity studies of diuretics in F344 rats and B6C3F1 mice. J. Appl. Toxicol. 1990; 10: 369-78.
20. Loube SD, Quirk RA. Breast cancer associated with administration of spironolactone. Lancet 1975; ii: 1428-9.
21. Huberman E, Sachs L. Mutability of different genetic loci in mammalian cells by metabolically activated carcinogenic polycyclic hydrocarbons. Proc. Natl Acad. Sci. USA 1976; 73: 188-92.